Adam Schoenfeld

34PUBLICATIONS
256CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung Cancer.

|May 05, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

|Jan 14, 2026
Timing Is of the Essence: Sequencing Immune Checkpoint Blockade and Radiotherapy for Success in Lung Cancer.

Florence K Keane, Adam J Schoenfeld

|Dec 21, 2025
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer.

Xinan Wang, Biagio Ricciuti, Arielle Elkrief

Pageof 6

Frequent Collaborators

10 joint publications

Charles M Rudin

8 joint publications

Arielle Elkrief

7 joint publications

Biagio Ricciuti

7 joint publications

Matthew Hellmann